Specific and non-specific responses in host resistance to tumors

Insights

Tumor immunotherapy shows promise by manipulating host recognition of tumor antigens. However, naturally occurring tumors often resist treatment, requiring alternative immune strategies like macrophage and natural killer cell activation.

Area of Science:

  • Immunology
  • Oncology
  • Cancer Research

Background:

  • Host immune recognition of tumor-associated antigens can be harnessed for cancer rejection.
  • Effective cancer immunotherapy relies on appropriate tumor antigen expression levels.
  • Naturally arising tumors in rodents often exhibit resistance to active specific immunotherapy.

Purpose of the Study:

  • To investigate the mechanisms of tumor rejection through host immune manipulation.
  • To explore the efficacy of immunotherapy against naturally occurring rodent tumors.
  • To understand the role of T lymphocytes and alternative immune cells in tumor response.

Main Methods:

  • Analysis of tumor antigen expression levels.
  • Evaluation of active specific immunotherapy in rodent tumor models.
  • Assessment of T lymphocyte responses and their tumoricidal activity.
  • Investigation of non-specific immunity mediated by macrophages and natural killer cells.

Main Results:

  • Tumor rejection is achievable by manipulating host recognition of tumor antigens.
  • Active specific immunotherapy is effective against tumors induced by extrinsic agents.
  • Naturally arising rodent tumors show limited response to current immunotherapy approaches.
  • Cytotoxic T cells are not always effective, necessitating alternative immune activation.

Conclusions:

  • Successful tumor rejection depends on host immune system manipulation and tumor antigen presentation.
  • While T lymphocytes are key, alternative immune pathways involving activated macrophages and natural killer cells are crucial for combating resistant tumors.
  • Future cancer immunotherapy strategies may need to incorporate augmentation of non-specific immunity for broader efficacy.

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Special Features of Adaptive Immunity01:20

Special Features of Adaptive Immunity

The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...